Trinity Biotech acquires US firm

TRINITY Biotech has completed the acquisition of Research Diagnostics, of Flanders, New Jersey.

Trinity Biotech has acquired the business for $4.2 million in cash. RDI provides a range of immunodiagnostic products.

The company’s revenue and profit performance has shown consistent growth with sales last year in excess of US$5m. The acquisition is expected to be accretive in the current financial year.